Get App Open
In App
Open App
you are here:

Eris Lifesciences Ltd.

BSE: 540596 | NSE: ERIS |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category
Series: EQ | ISIN: INE406M01024 | SECTOR: Pharmaceuticals & Drugs

BSE Live

Jun 02, 16:01
637.55 -2.20 (-0.34%)
Volume
AVERAGE VOLUME
5-Day
943
10-Day
1,035
30-Day
2,581
1,091
  • Prev. Close

    639.75

  • Open Price

    641.80

  • Bid Price (Qty.)

    632.95 (1)

  • Offer Price (Qty.)

    641.50 (23)

NSE Live

Jun 02, 15:47
638.20 -2.35 (-0.37%)
Volume
AVERAGE VOLUME
5-Day
27,199
10-Day
21,983
30-Day
48,993
14,078
  • Prev. Close

    640.55

  • Open Price

    634.15

  • Bid Price (Qty.)

    0.00 (0)

  • Offer Price (Qty.)

    0.00 (0)

Financials

2022 2021 2020 2019 2018
Nine Months Results of Eris Lifesciences (in Rs. Cr.) Dec '22 Dec '21 Dec '20 Dec '19 Dec '18  
Net Sales/Income from operations 998.77 916.65 835.97 777.68 686.52  
Other Operating Income 17.38 16.94 16.02 11.82 11.59  
Total Income From Operations 1,016.14 933.59 851.99 789.49 698.11  
EXPENDITURE  
Consumption of Raw Materials 89.05 87.56 77.34 52.86 46.64  
Purchase of Traded Goods 84.07 52.69 81.83 59.33 58.08  
Increase/Decrease in Stocks 14.56 9.50 -10.73 19.26 -2.72  
Power & Fuel -- -- -- -- --  
Employees Cost 191.89 169.54 160.67 140.73 125.73  
Depreciation 47.37 36.39 27.50 31.92 21.55  
Excise Duty -- -- -- -- --  
Admin. And Selling Expenses -- -- -- -- --  
R & D Expenses -- -- -- -- --  
Provisions And Contingencies -- -- -- -- --  
Exp. Capitalised -- -- -- -- --  
Other Expenses 242.94 231.92 219.58 234.96 198.64  
P/L Before Other Inc. , Int., Excpt. Items & Tax 346.25 345.99 295.79 250.44 250.19  
Other Income 13.00 19.94 7.25 15.53 20.90  
P/L Before Int., Excpt. Items & Tax 359.26 365.92 303.04 265.97 271.08  
Interest 17.85 2.01 0.58 1.59 18.41  
P/L Before Exceptional Items & Tax 341.40 363.91 302.46 264.38 252.67  
Exceptional Items -- -- -- -- --  
P/L Before Tax 341.40 363.91 302.46 264.38 252.67  
Tax 31.23 33.43 21.21 28.21 19.71  
P/L After Tax from Ordinary Activities 310.17 330.48 281.26 236.17 232.97  
Prior Year Adjustments -- -- -- -- --  
Extra Ordinary Items -- -- -- -- --  
Net Profit/(Loss) For the Period 310.17 330.48 281.26 236.17 232.97  
Equity Share Capital 13.60 13.59 13.58 13.75 13.75  
Reserves Excluding Revaluation Reserves -- -- -- -- --  
Equity Dividend Rate (%) -- -- -- -- --  
EPS Before Extra Ordinary  
Basic EPS 22.81 24.33 20.71 17.17 16.94  
Diluted EPS 22.80 24.32 20.69 17.15 16.93  
EPS After Extra Ordinary  
Basic EPS. 22.81 24.33 20.71 17.17 16.94  
Diluted EPS. 22.80 24.32 20.69 17.15 16.93  
Public Share Holding  
No Of Shares (Crores) -- -- -- -- --  
Share Holding (%) -- -- -- -- --  
Promoters and Promoter Group Shareholding  
a) Pledged/Encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
b) Non-encumbered  
- Number of shares (Crores) -- -- -- -- --  
- Per. of shares (as a % of the total sh. of prom. and promoter group) -- -- -- -- --  
- Per. of shares (as a % of the total Share Cap. of the company) -- -- -- -- --  
Source : Dion Global Solutions Limited

Results of Pharmaceuticals & Drugs Sector

No News.
No News.
No News.
No News.